Computational Virtual Screening of Sulfonylurea chalcones as New Class of 5-Lipoxygenase Inhibitors by Molecular Docking Studies
暂无分享,去创建一个
Bharat KumarBugata | S. V G K Kaladhar Dowluru | Vasudeva Rao Avupati | V. Avupati | S. V. G. K. K. Dowluru | Bharat KumarBugata
[1] Mechanism of action of adverse drug reactions: an overview. , 1997, Pharmacoepidemiology and drug safety.
[2] T. Schmidt,et al. Autoregulation of corticosteroid receptors. How, when, where, and why? , 1994, Receptor.
[3] J. Mccammon,et al. Accommodating Protein Flexibility in Computational Drug Design 1 , 2 , 2000 .
[4] V. Avupati,et al. De novo Based Ligand generation and Docking studies of PPARδ Agonists: Correlations between Predicted Biological activity vs. Biopharmaceutical Descriptors , 2010 .
[5] R. Storn,et al. Differential Evolution - A simple and efficient adaptive scheme for global optimization over continuous spaces , 2004 .
[6] Schmidt Tj,et al. Autoregulation of corticosteroid receptors. How, when, where, and why? , 1994 .
[7] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[8] V. Avupati,et al. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents. , 2012, Bioorganic & medicinal chemistry letters.
[9] Rainer Storn,et al. Differential Evolution – A Simple and Efficient Heuristic for global Optimization over Continuous Spaces , 1997, J. Glob. Optim..
[10] L. Bohlin,et al. Flavan-3-ols Isolated from Some Medicinal Plants Inhibiting COX-1 and COX-2 Catalysed Prostaglandin Biosynthesis , 1998, Planta medica.
[11] David B. Fogel,et al. Docking Conformationally Flexible Small Molecules into a Protein Binding Site through Evolutionary Programming , 1995, Evolutionary Programming.
[12] J. D. Elliott,et al. Drug discovery in the next millennium. , 2000, Annual review of pharmacology and toxicology.
[13] Larry L. Peterson,et al. Reasoning about naming systems , 1993, TOPL.
[14] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[15] C Y Ung,et al. Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants. , 2002, The American journal of Chinese medicine.
[16] L Lasagna,et al. New drug development in the United States from 1963 to 1992 , 1994, Clinical pharmacology and therapeutics.
[17] O. Werz,et al. Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds , 2005 .
[18] B. Shoichet,et al. Flexible ligand docking using conformational ensembles , 1998, Protein science : a publication of the Protein Society.
[19] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 1995, 117, 5179−5197 , 1996 .
[20] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[21] L Lasagna,et al. New drug development in the United States from 1963 to 1990 , 1991, Clinical pharmacology and therapeutics.
[22] I. Kuntz,et al. Flexible ligand docking: A multistep strategy approach , 1999, Proteins.
[23] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[24] G. N. Ramachandran,et al. Conformation of polypeptides and proteins. , 1968, Advances in protein chemistry.
[25] R Nussinov,et al. Flexible docking allowing induced fit in proteins: Insights from an open to closed conformational isomers , 1998, Proteins.
[26] Y. Z. Chen,et al. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. , 2001, Journal of molecular graphics & modelling.